Immune Health Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The immune health supplements market size was valued at USD 15.91 billion in 2025 and estimated to grow from USD 17.11 billion in 2026 to reach USD 24.61 billion by 2031, at a CAGR of 7.55% during the forecast period (2026-2031). This report is Segmented by Product Type (Vitamins and Minerals, Probiotics, and More), Form (Capsules and Softgels, Powders, and More), End User (Adults and Kids), Distribution Channel (Supermarkets/Hypermarkets, Online Retailers, and More), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Immune Health Supplements Market Trends and Insights

Aging populations globally seek immunity-boosting support

As individuals age, their immune systems weaken, a process called immunosenescence. To counter this, many seniors use supplements like zinc, vitamin D, probiotics, and antioxidants. The World Health Organization estimates the global population aged 60+ will grow from 1 billion in 2020 to 1.4 billion by 2030 and double to 2.1 billion by 2050, with those aged 80+ tripling to 426 million. This shift has increased supplement use among older adults. The NIH Office of Dietary Supplements has included research on aging-related supplements in its 2025-2029 strategic plan. Manufacturers are addressing aging concerns like inflammation and metabolism with specialized products. For example, Abbott’s Ensure line, focused on adult nutrition, achieved USD 4.4 billion in sales in 2024, with 9% organic growth, as reported by the company.

Enhanced focus on immunity post-COVID-19 fueling market expansion

Awareness of immune health has surged since the COVID-19 pandemic, with individuals, especially those with pre-existing conditions, taking proactive steps to improve their health. In 2024, the FDA expanded its Dietary Supplement Ingredient Directory, enhancing consumer trust and simplifying supplement selection. As of June 2025, the World Health Organization reported 359,000 active COVID-19 cases globally, emphasizing the ongoing need for immune support. Social media trends reveal strong commercial ties to immunity discussions, highlighting brand innovation and investment. These factors are driving demand for immune health supplements and fueling market growth.

Lack of standardized regulations across regions

Immune supplement manufacturers face challenges due to inconsistent regulatory standards across regions, which increase costs and delay product launches. For instance, the EU’s Food Supplements Directive 2002/46/EC aimed to unify regulations but allows member states to set their own rules, complicating launches. In the U.S., the FDA's 75-day premarket notification for New Dietary Ingredients adds complexity, especially for e-commerce-focused brands. Varying probiotic labeling rules globally further hinder standardized claims. These issues particularly burden smaller businesses, slowing innovation, hindering international expansion, and impacting the immune health supplements market's growth.

Other drivers and restraints analyzed in the detailed report include:

• Chronic disease prevalence drives preventive supplement use
• Demand for personalized nutrition stimulates innovation
• Supply chain disruptions affecting raw material availability

Segment Analysis

In 2025, vitamins and minerals led the immune health supplements market, contributing 33.85% of the revenue. Their popularity stems from their ability to address common nutrient deficiencies and their widespread acceptance by healthcare professionals. Meanwhile, probiotics are experiencing the fastest growth, with a projected CAGR of 9.52% through 2031. This rapid expansion is supported by clinical studies that highlight the benefits of specific probiotic strains in boosting upper respiratory immunity. Regulatory approvals, such as EFSA’s clearance of paramylon in 2024 and the FDA’s GRAS status for Bacillus subtilis NRRL 68053, have further enhanced consumer trust in probiotics. As a result, probiotics are expected to gain significant market share, gradually overtaking traditional multivitamins.

The market is also seeing a wave of innovation with the introduction of new ingredients like postbiotic metabolites, yeast-fermentate concentrates, and algae-derived beta-glucans. For instance, clinical studies on EpiCor have shown its effectiveness in reducing cold symptoms in children, making it a promising option for pediatric health. These advancements are supported by intellectual property protections, which help companies maintain a competitive edge and secure higher profit margins. As research expands to include broader health benefits, such as microbiome modulation in addition to traditional immune markers, the market continues to reward companies that invest in research and development.

In 2025, tablets dominated the market with a 31.20% share. Their affordability, precise dosing, and convenience in combining multiple vitamins make them a top choice for consumers. Yet, gummies are on the rise, boasting a robust CAGR of 8.55%. Adults are increasingly opting for gummies due to their pleasant taste and seamless integration into daily routines. While leading brands like Church & Dwight have set the bar high, competition has surged with over 60 branded players entering the fray. In response to concerns about sugar content, brands have introduced reduced-calorie options, and pectin-based formulations are now catering to vegan consumers. Historically, gummies struggled with bioavailability, particularly for sensitive nutrients like probiotics and omega oils.

Capsules and softgels attract consumers who prioritize a pharmaceutical-grade experience and efficient delivery of fat-soluble nutrients. Powders, on the other hand, are the go-to choice in sports nutrition and elderly care, owing to their adjustable dosing and ease of use for those with swallowing challenges. This ongoing innovation in delivery formats empowers brands to address the diverse preferences of consumers spanning various age groups and lifestyles. Such diversification not only meets specific consumer needs but also cultivates strong loyalty within the expansive immune health supplements market.

Complete Report Scope:

• By Product Type
  • Vitamins and Minerals
  • Herbal/Botanical Extracts
  • Probiotics
  • Omega-3 Fatty Acids
  • Other Product Types
• By Form
  • Capsules and Softgels
  • Tablets
  • Gummies and Chewables
  • Powders
  • Other Forms
• By End User
  • Adults
  • Kids
• By Distribution Channel
  • Supermarkets/Hypermarkets
  • Specialty and Health Stores
  • Online Retailers
  • Other Distribution Channels
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Netherlands
    • Poland
    • Belgium
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Indonesia
    • South Korea
    • Thailand
    • Singapore
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • Egypt
    • Morocco
    • Turkey
    • Rest of Middle East and Africa

Geography Analysis

North America accounted for 26.85% of global revenue in 2025, driven by a strong culture of supplement use, high disposable incomes, and clear regulatory oversight from the FDA. Surveys from the National Institutes of Health (NIH) reveal that over 10% of U.S. adults specifically choose supplements for immune health. Canada and Mexico are also seeing steady growth, supported by integrated supply chains across North America, although potential tariff challenges remain. In Europe, spending on immune health supplements is comparable to North America, but the region faces varying regulations across member states. The European Food Safety Authority (EFSA) promotes trust with its evidence-based approach, allowing brands to position themselves as premium, though compliance costs remain a challenge. Countries like Germany, France, and the U.K. are seeing consistent demand for probiotic blends backed by clinical research, while Eastern Europe is gradually contributing to growth as disposable incomes rise and awareness about healthcare improves.

The Middle East and Africa is experiencing the fastest growth rate, with a CAGR of 9.07%, largely due to widespread vitamin D deficiencies and government-led initiatives promoting supplementation. Research in countries like Saudi Arabia and the UAE indicates that addressing vitamin D deficiencies could significantly reduce cardiovascular risks. Retailers in the region are aligning with local consumption habits by bundling immune health supplements with fortified dairy products and beverages. In the Asia-Pacific region, the combination of a large population and increasing urban stress is driving demand for immune health supplements. Countries like China and India are adopting products that blend traditional botanicals with modern nutrients, although affordability remains a key factor, leading to the popularity of sachets and stick-pack formats. Japan’s Food for Specified Health Use (FOSHU) system ensures scientific credibility, attracting a loyal customer base, particularly among older adults.

South America present long-term growth opportunities but face challenges such as currency fluctuations and weak regulatory enforcement, which can lead to counterfeit products entering the market. To address these issues, multinational companies are partnering with local distributors to navigate fragmented retail environments and educate consumers about the benefits of evidence-backed supplements. E-commerce is playing a significant role in breaking down geographic barriers, enabling even smaller, specialized brands to reach international customers. This trend is intensifying competition globally, as brands across regions strive to capture a share of the growing immune health supplements market.

List of Companies Covered in this Report:

• Amway Corp.
• Bayer AG
• Glanbia plc
• NOW Foods
• Cosmic Nutracos Solutions
• Herbalife Nutrition Ltd
• 21st Century HealthCare, Inc.
• Dr. Willmar Schwabe GmbH & Co. KG
• Abbott Laboratories
• Pfizer Inc.
• Nestle SA
• Otsuka Pharmaceutical Co., Ltd
• Kirin Holdings
• H&H International Holdings Limited
• BioGaia AB
• Church & Dwight Co.
• Jamieson Wellness Inc.
• Reckitt Benckiser Group plc
• Unilever plc
• Nature's Way

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support